Immune Biosolutions Inc
3 clinical trials · Sponsor
◉ Watch Immune Biosolutions Inc
| Record | Firm | Date |
|---|---|---|
| Study in Adults to Assess the Safety and Efficacy of Inhaled IBIO123, for Post-exposure Prophylaxis of COVID-19 (NCT05639166) | Immune Biosolutions Inc | 2023-02-18 |
| Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness (NCT05303376) | Immune Biosolutions Inc | 2022-02-22 |
| Phase 1/2 Study to Evaluate the Efficacy and Safety of Inhaled IBIO123 in Participants With Mild to Moderate COVID-19 Illness (NCT05298813) | Immune Biosolutions Inc | 2021-09-29 |
Track Immune Biosolutions Inc automatically
Every clearance here is in the API, with alerts when new ones post.